Selective orexin 2 receptor agonist TAK-925 to treat narcolepsy: results of a randomized, double-blind, placebo-controlled, multiple-ascending-dose, phase 1 study in patients with narcolepsy type 2

被引：0
|
作者：
Tanaka, S. -I. [1 ]
Evans, R. [2 ]
Alexander, R. [2 ]
Imazaki, M. [1 ]
Touno, S. [1 ]
Shimizu, K. [1 ]
Wu, J. [2 ]
Faessel, H. [2 ]
Ratti, E. [2 ]
Hartman, D. [1 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Takeda Dev Ctr Japan, Osaka, Japan
[2] Takeda Pharmaceut Int Co, Neurosci Therapeut Area Unit, Cambridge, MA USA
来源：
JOURNAL OF SLEEP RESEARCH | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P206
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [31] QUALITY OF LIFE IN PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL STUDY OF JZP-258 IN ADULTS WITH NARCOLEPSY WITH CATAPLEXY
    Foldvary-Schaefer, N.
    Thorpy, M. J.
    Dauvilliers, Y.
    Roy, A.
    Tang, L.
    Skowronski, R.
    Sonka, K.
    Bogan, R. K.
    SLEEP, 2020, 43 : A281 - A282
  • [32] Quality of Life in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of JZP-258 in Adults with Narcolepsy with Cataplexy
    Foldvary-Schaefer, Nancy
    Thorpy, Michael J.
    Dauvilliers, Yves
    Roy, Asim
    Tang, Lihua
    Skowronski, Roman
    Sonka, Karel
    Bogan, Richard K.
    ANNALS OF NEUROLOGY, 2020, 88 : S254 - S255
  • [33] Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
    Furie, Richard A.
    Hough, Douglas R.
    Gaudy, Allison
    Ye, Ying
    Korish, Shimon
    Delev, Nikolay
    Weiswasser, Michael
    Zhan, Xiaojiang
    Schafer, Peter H.
    Werth, Victoria P.
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [34] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
    Earle E Bain
    Weining Robieson
    Yili Pritchett
    Tushar Garimella
    Walid Abi-Saab
    George Apostol
    James J McGough
    Mario D Saltarelli
    Neuropsychopharmacology, 2013, 38 : 405 - 413
  • [35] A randomized, double-blind, placebo-controlled Phase 2 study of α4β2 agonist ABT-894 in adults with ADHD
    Bain, Earle
    Robieson, Weining
    Garimella, Tushar
    Abi-Saab, Walid
    Apostol, George
    Saltarelli, Mario D.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 1043 - 1043
  • [36] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
    Bain, Earle E.
    Robieson, Weining
    Pritchett, Yili
    Garimella, Tushar
    Abi-Saab, Walid
    Apostol, George
    McGough, James J.
    Saltarelli, Mario D.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (03) : 405 - 413
  • [37] Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
    Makoto Uchiyama
    Daiji Kambe
    Yumiko Imadera
    Yu Kajiyama
    Hiroki Ogo
    Naohisa Uchimura
    Psychopharmacology, 2022, 239 : 2143 - 2154
  • [38] Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
    Uchiyama, Makoto
    Kambe, Daiji
    Imadera, Yumiko
    Kajiyama, Yu
    Ogo, Hiroki
    Uchimura, Naohisa
    PSYCHOPHARMACOLOGY, 2022, 239 (07) : 2143 - 2154
  • [39] A Randomized, Double-Blind, Placebo-Controlled Study for Diacerein in Patients with Inadequately Controlled Type 2 Diabetes Mellitus
    Pei, Dee
    Huang, Chien-Ning
    Chen, Ching-Chu
    Hsia, Te-Lin
    Lu, Wei-Shu
    Lin, Yi-Yin
    Ku, M. Sherry
    DIABETES, 2011, 60 : A84 - A85
  • [40] A randomized, double-blind, placebo-controlled, Phase 2 study: the efficacy of fasudil in patients with stable angina
    Vicari, RM
    Smith, WB
    Chaitman, B
    Chrysant, SG
    Tonkon, MJ
    Bitter, N
    Weiss, RJ
    Thadani, U
    EUROPEAN HEART JOURNAL, 2004, 25 : 138 - 138
12345